CA2901532A1 - Systems and methods for making a laminar ventricular partitioning device - Google Patents
Systems and methods for making a laminar ventricular partitioning device Download PDFInfo
- Publication number
- CA2901532A1 CA2901532A1 CA2901532A CA2901532A CA2901532A1 CA 2901532 A1 CA2901532 A1 CA 2901532A1 CA 2901532 A CA2901532 A CA 2901532A CA 2901532 A CA2901532 A CA 2901532A CA 2901532 A1 CA2901532 A1 CA 2901532A1
- Authority
- CA
- Canada
- Prior art keywords
- rib
- sheet
- implant
- assembly
- frame
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 58
- 238000000638 solvent extraction Methods 0.000 title claims description 76
- 230000002861 ventricular Effects 0.000 title description 9
- 239000007943 implant Substances 0.000 claims abstract description 40
- 238000010438 heat treatment Methods 0.000 claims abstract description 22
- 238000007493 shaping process Methods 0.000 claims abstract description 20
- 230000003247 decreasing effect Effects 0.000 claims abstract description 16
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 claims description 101
- 239000000463 material Substances 0.000 claims description 72
- 239000012815 thermoplastic material Substances 0.000 claims description 43
- 239000012528 membrane Substances 0.000 claims description 31
- 210000005240 left ventricle Anatomy 0.000 claims description 16
- 230000004927 fusion Effects 0.000 claims description 13
- 238000003825 pressing Methods 0.000 claims description 10
- 230000000295 complement effect Effects 0.000 claims description 8
- 238000002407 reforming Methods 0.000 claims description 7
- -1 polyethylene Polymers 0.000 description 59
- 239000004698 Polyethylene Substances 0.000 description 52
- 229920000573 polyethylene Polymers 0.000 description 52
- 210000002216 heart Anatomy 0.000 description 29
- 238000003475 lamination Methods 0.000 description 23
- 210000005242 cardiac chamber Anatomy 0.000 description 19
- 239000004744 fabric Substances 0.000 description 16
- 239000012530 fluid Substances 0.000 description 13
- 206010007559 Cardiac failure congestive Diseases 0.000 description 12
- 239000004810 polytetrafluoroethylene Substances 0.000 description 12
- 229940058401 polytetrafluoroethylene Drugs 0.000 description 12
- 230000008569 process Effects 0.000 description 12
- 206010019280 Heart failures Diseases 0.000 description 11
- 229920001169 thermoplastic Polymers 0.000 description 11
- 239000004416 thermosoftening plastic Substances 0.000 description 11
- 238000004891 communication Methods 0.000 description 8
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 239000000835 fiber Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000011159 matrix material Substances 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 238000005192 partition Methods 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000002513 implantation Methods 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 4
- 229920001903 high density polyethylene Polymers 0.000 description 4
- 239000004700 high-density polyethylene Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 229910001000 nickel titanium Inorganic materials 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 239000000560 biocompatible material Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000032798 delamination Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 210000003709 heart valve Anatomy 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 206010033372 Pain and discomfort Diseases 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 210000005246 left atrium Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 210000004115 mitral valve Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12122—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder within the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00526—Methods of manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00831—Material properties
- A61B2017/00955—Material properties thermoplastic
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Prostheses (AREA)
- External Artificial Organs (AREA)
- Surgical Instruments (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/827,927 US9332992B2 (en) | 2004-08-05 | 2013-03-14 | Method for making a laminar ventricular partitioning device |
| US13/827,927 | 2013-03-14 | ||
| PCT/US2014/027364 WO2014152461A2 (en) | 2013-03-14 | 2014-03-14 | Systems and methods for making a laminar ventricular partitioning device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2901532A1 true CA2901532A1 (en) | 2014-09-25 |
Family
ID=50442723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2901532A Abandoned CA2901532A1 (en) | 2013-03-14 | 2014-03-14 | Systems and methods for making a laminar ventricular partitioning device |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP2967570A2 (enExample) |
| JP (1) | JP2016512141A (enExample) |
| KR (2) | KR101713607B1 (enExample) |
| CN (2) | CN104042300B (enExample) |
| AU (1) | AU2014239608A1 (enExample) |
| BR (1) | BR112015021613A2 (enExample) |
| CA (1) | CA2901532A1 (enExample) |
| IL (1) | IL240520A0 (enExample) |
| RU (1) | RU2015143955A (enExample) |
| WO (1) | WO2014152461A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016048802A1 (en) * | 2014-09-28 | 2016-03-31 | Cardiokinetix, Inc. | Apparatuses for treating cardiac dysfunction |
| CN104706444B (zh) * | 2015-03-03 | 2017-07-18 | 上海形状记忆合金材料有限公司 | 左心室减容装置 |
| CN105476733B (zh) * | 2016-01-27 | 2017-09-01 | 张刚成 | 心脏减容装置 |
| CN106073947A (zh) * | 2016-08-29 | 2016-11-09 | 关丽鹃 | 心脏减容系统 |
| WO2018064548A1 (en) * | 2016-09-29 | 2018-04-05 | Innervate Medical, Llc | Uses of minimally invasive systems and methods for neurovascular signal management including endovascular electroencephalography and related techniques foe epilepsy detection and treatment |
| KR20190137769A (ko) * | 2017-01-05 | 2019-12-11 | 하모니 디벨럽먼트 그룹 인코포레이티드 | 심실 기능 및 모델링을 실시하기 위한 역류성 분사, 체적, 및 힘을 포획하기 위한 팽창가능한 디바이스 |
| WO2019006152A1 (en) | 2017-06-28 | 2019-01-03 | Harmony Development Group, Inc. | INFLATABLE TRANSDUCTION IMPLANT SYSTEM COMPRISING AN ANNULAR DOUBLE FORCE TRANSDUCTION IMPLANT |
| US11167122B2 (en) | 2018-03-05 | 2021-11-09 | Harmony Development Group, Inc. | Force transducting implant system for the mitigation of atrioventricular pressure gradient loss and the restoration of healthy ventricular geometry |
| CN109820551B (zh) * | 2019-02-22 | 2022-03-01 | 北京大学深圳研究生院 | 一种充气式心室隔离装置 |
| CN110974349B (zh) * | 2019-11-25 | 2022-08-02 | 湖南瑞康通科技发展有限公司 | 取栓装置及取栓组件 |
| US20240216098A1 (en) * | 2022-12-28 | 2024-07-04 | Coherex Medical, Inc. | Cover for medical device, system and method thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100030256A1 (en) * | 1997-11-12 | 2010-02-04 | Genesis Technologies Llc | Medical Devices and Methods |
| US7128073B1 (en) * | 1998-11-06 | 2006-10-31 | Ev3 Endovascular, Inc. | Method and device for left atrial appendage occlusion |
| US8257428B2 (en) * | 1999-08-09 | 2012-09-04 | Cardiokinetix, Inc. | System for improving cardiac function |
| US8529430B2 (en) * | 2002-08-01 | 2013-09-10 | Cardiokinetix, Inc. | Therapeutic methods and devices following myocardial infarction |
| US20060030881A1 (en) * | 2004-08-05 | 2006-02-09 | Cardiokinetix, Inc. | Ventricular partitioning device |
| US20060106420A1 (en) * | 2004-11-12 | 2006-05-18 | Medtronic Vascular, Inc. | Patch for treating a septal defect |
| US9545300B2 (en) * | 2004-12-22 | 2017-01-17 | W. L. Gore & Associates, Inc. | Filament-wound implantable devices |
| WO2008150346A1 (en) * | 2007-05-31 | 2008-12-11 | Rex Medical, L.P. | Closure device for left atrial appendage |
| US9414842B2 (en) * | 2007-10-12 | 2016-08-16 | St. Jude Medical, Cardiology Division, Inc. | Multi-component vascular device |
| US8690911B2 (en) * | 2009-01-08 | 2014-04-08 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
| CA2758067A1 (en) * | 2009-04-10 | 2010-10-14 | Cardiokinetix, Inc. | Sealing and filling ventricular partitioning devices to improve cardiac function |
| CA2958333A1 (en) * | 2009-06-17 | 2010-12-23 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
| US20110054515A1 (en) * | 2009-08-25 | 2011-03-03 | John Bridgeman | Device and method for occluding the left atrial appendage |
| WO2011056578A2 (en) * | 2009-10-26 | 2011-05-12 | Cardiokinetix, Inc. | Ventricular volume reduction |
| KR101070811B1 (ko) * | 2011-02-18 | 2011-10-06 | 강원대학교산학협력단 | 심실구획장치 |
-
2014
- 2014-03-14 KR KR1020157028718A patent/KR101713607B1/ko not_active Expired - Fee Related
- 2014-03-14 RU RU2015143955A patent/RU2015143955A/ru not_active Application Discontinuation
- 2014-03-14 KR KR1020177005196A patent/KR20170024147A/ko not_active Withdrawn
- 2014-03-14 WO PCT/US2014/027364 patent/WO2014152461A2/en not_active Ceased
- 2014-03-14 CN CN201410097592.3A patent/CN104042300B/zh not_active Expired - Fee Related
- 2014-03-14 AU AU2014239608A patent/AU2014239608A1/en not_active Abandoned
- 2014-03-14 EP EP14716179.8A patent/EP2967570A2/en not_active Withdrawn
- 2014-03-14 CN CN201420118276.5U patent/CN204072201U/zh not_active Expired - Fee Related
- 2014-03-14 CA CA2901532A patent/CA2901532A1/en not_active Abandoned
- 2014-03-14 JP JP2016502416A patent/JP2016512141A/ja active Pending
- 2014-03-14 BR BR112015021613A patent/BR112015021613A2/pt not_active IP Right Cessation
-
2015
- 2015-08-12 IL IL240520A patent/IL240520A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014152461A3 (en) | 2014-12-04 |
| CN204072201U (zh) | 2015-01-07 |
| RU2015143955A (ru) | 2017-04-20 |
| BR112015021613A2 (pt) | 2017-07-18 |
| JP2016512141A (ja) | 2016-04-25 |
| EP2967570A2 (en) | 2016-01-20 |
| IL240520A0 (en) | 2015-10-29 |
| CN104042300A (zh) | 2014-09-17 |
| KR20170024147A (ko) | 2017-03-06 |
| WO2014152461A2 (en) | 2014-09-25 |
| KR101713607B1 (ko) | 2017-03-09 |
| KR20150127242A (ko) | 2015-11-16 |
| CN104042300B (zh) | 2017-11-28 |
| AU2014239608A1 (en) | 2015-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7897086B2 (en) | Method of making a laminar ventricular partitioning device | |
| US9332992B2 (en) | Method for making a laminar ventricular partitioning device | |
| CA2901532A1 (en) | Systems and methods for making a laminar ventricular partitioning device | |
| US10064696B2 (en) | Devices and methods for delivering an endocardial device | |
| US7582051B2 (en) | Peripheral seal for a ventricular partitioning device | |
| US8398537B2 (en) | Peripheral seal for a ventricular partitioning device | |
| JP6799526B2 (ja) | 心不全の治療のための装置及び方法 | |
| WO2023199267A1 (en) | Interatrial shunt with expanded neck region | |
| CN204909516U (zh) | 行进通过患者的脉管系统的系统及对患者的心腔执行外科手术的套件 | |
| US20080228205A1 (en) | Ventricular partitioning device | |
| JP2012523267A (ja) | 心臓機能改善のための密封充填心室分割装置 | |
| CN204169959U (zh) | 包括可扩张装置和递送导管的系统 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20151216 |
|
| FZDE | Discontinued |
Effective date: 20190208 |